The global herpes labialis treatment market is estimated to be valued at USD 1,238.7 million in 2025 and is projected to reach USD 1,887.1 million by 2035, registering a CAGR of 4.3% over the forecast ...

New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today in ...

Assembly Biosciences has dosed the first subject in the Phase Ia/b study’s Phase Ib portion, evaluating ABI-1179, the ...

Long before chewing gum came in shiny foil wrappers with watermelon flavors and whitening promises, our ancestors were ...

The two-dose vaccine has been shown to have benefits beyond just developing shingles, although that alone should be impetus ...

The cold sore-causing Herpes Simplex Virus (HSV-1) hijacks human cells and reconfigures its DNA within just an hour after ...

Kochayappan, a 5-year-old elephant calf at Konni training centre, found dead. Herpes virus suspected; post-mortem to confirm cause of death ...

The Phase 1b study will evaluate the safety and antiviral activity of weekly oral doses of ABI-1179 over a 29-day treatment period in participants with recurrent genital herpes. Antiviral activity ...

"I went from a minor toothache to almost dead in about three days. So any time I hear someone question whether or not to get ...

I was in an important meeting. One that would chart the course of an organisation for the next few years, covering a very ...

If you’ve been exposed to the herpes virus, it can take anywhere from 2 to 10 days for symptoms to appear and for the virus to be detected on a test. Learn more.

New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today in ...